Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The stock traded as high as $88.24 and last traded at $88.24, with a volume of 4000 shares changing hands. The stock had previously closed at $75.00.
Pharma Mar Price Performance
The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01. The firm’s fifty day moving average price is $79.25 and its 200 day moving average price is $60.13.
Pharma Mar Company Profile
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
See Also
- Five stocks we like better than Pharma Mar
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Consumer Stocks Call Option Traders Are Betting Big On
- 3 Best Fintech Stocks for a Portfolio Boost
- Duolingo: An Unexpected Benefactor From the TikTok Ban
- Do ETFs Pay Dividends? What You Need to Know
- Trump Index: 6 Companies Linked to Trump’s Cabinet Worth Watching
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
